BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 25424887)

  • 1. Nuclear imaging for cardiac amyloidosis.
    Noordzij W; Glaudemans AW; Longhi S; Slart RH; Lorenzini M; Hazenberg BP; Rapezzi C
    Heart Fail Rev; 2015 Mar; 20(2):145-54. PubMed ID: 25424887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging in systemic amyloidosis.
    Sachchithanantham S; Wechalekar AD
    Br Med Bull; 2013; 107():41-56. PubMed ID: 23896486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear imaging modalities for cardiac amyloidosis.
    Bokhari S; Shahzad R; Castaño A; Maurer MS
    J Nucl Cardiol; 2014 Feb; 21(1):175-84. PubMed ID: 24162886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Advances in Cardiovascular Imaging Relevant to the Management of Patients with Suspected Cardiac Amyloidosis.
    White JA; Fine NM
    Curr Cardiol Rep; 2016 Aug; 18(8):77. PubMed ID: 27319007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of imaging in the diagnosis and management of patients with cardiac amyloidosis: state of the art review and focus on emerging nuclear techniques.
    Aljaroudi WA; Desai MY; Tang WH; Phelan D; Cerqueira MD; Jaber WA
    J Nucl Cardiol; 2014 Apr; 21(2):271-83. PubMed ID: 24347127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Misconceptions and Facts About Cardiac Amyloidosis.
    Nguyen FD; Rodriguez M; Krittanawong C; Witteles R; Lenihan DJ
    Am J Cardiol; 2021 Dec; 160():99-105. PubMed ID: 34610875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical use of differential nuclear medicine modalities in patients with ATTR amyloidosis.
    Noordzij W; Glaudemans AW; Slart RH; Dierckx RA; Hazenberg BP
    Amyloid; 2012 Dec; 19(4):208-11. PubMed ID: 22913327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 11C-Pittsburgh B PET imaging in cardiac amyloidosis.
    Lee SP; Lee ES; Choi H; Im HJ; Koh Y; Lee MH; Kwon JH; Paeng JC; Kim HK; Cheon GJ; Kim YJ; Kim I; Yoon SS; Seo JW; Sohn DW
    JACC Cardiovasc Imaging; 2015 Jan; 8(1):50-59. PubMed ID: 25499132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Imaging of Cardiac Amyloidosis.
    Pelletier-Galarneau M; Abikhzer G; Giraldeau G; Harel F
    Curr Cardiol Rep; 2019 Feb; 21(3):12. PubMed ID: 30815746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Molecular Imaging in the Assessment of Cardiac Amyloidosis: State-of-the-Art.
    Popescu C; Burger IA
    Curr Radiopharm; 2021; 14(3):228-241. PubMed ID: 32525789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in the noninvasive strategies of cardiac amyloidosis.
    Zhao L; Fang Q
    Heart Fail Rev; 2016 Nov; 21(6):703-721. PubMed ID: 27554493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Echocardiography and magnetic resonance imaging in cardiac amyloidosis.
    von Kemp K; Beckers R; Vandenweghe J; Taeymans Y; Osteaux M; Block P
    Acta Cardiol; 1989; 44(1):29-36. PubMed ID: 2711796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Nuclear Imaging in Cardiac Amyloidosis Management: Clinical Evidence and Review of Literature.
    Frantellizzi V; Cosma L; Pani A; Pontico M; Conte M; De Angelis C; De Vincentis G
    Curr Med Imaging; 2020; 16(8):957-966. PubMed ID: 33081658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced Nuclear Medicine and Molecular Imaging in the Diagnosis of Cardiomyopathy.
    Yang M; Arsanjani R; Roarke MC
    AJR Am J Roentgenol; 2020 Nov; 215(5):1208-1217. PubMed ID: 32901569
    [No Abstract]   [Full Text] [Related]  

  • 15. Paediatric nuclear medicine imaging.
    Biassoni L; Easty M
    Br Med Bull; 2017 Sep; 123(1):127-148. PubMed ID: 28910997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical use of Cardiac Nuclear Medicine in Germany].
    Diekmann J; Bengel FM
    Dtsch Med Wochenschr; 2022 Apr; 147(9):538-548. PubMed ID: 35468635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and treatment of cardiac amyloidosis: position statement of the German Cardiac Society (DGK).
    Yilmaz A; Bauersachs J; Bengel F; Büchel R; Kindermann I; Klingel K; Knebel F; Meder B; Morbach C; Nagel E; Schulze-Bahr E; Aus dem Siepen F; Frey N
    Clin Res Cardiol; 2021 Apr; 110(4):479-506. PubMed ID: 33459839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel strategies for the diagnosis and treatment of cardiac amyloidosis.
    Palladini G; Milani P; Merlini G
    Expert Rev Cardiovasc Ther; 2015 Nov; 13(11):1195-211. PubMed ID: 26496239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developing imaging biomarkers for myocardial involvement in amyloidosis: challenge and opportunity.
    Udelson JE
    JACC Cardiovasc Imaging; 2015 Jan; 8(1):60-62. PubMed ID: 25592696
    [No Abstract]   [Full Text] [Related]  

  • 20. Assessment of relative sensitivities of noninvasive tests for cardiac amyloidosis in documented cardiac amyloidosis.
    Simons M; Isner JM
    Am J Cardiol; 1992 Feb; 69(4):425-7. PubMed ID: 1734663
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.